🇺🇸 FDA
Patent

US 10213381

Solid solution compositions and use in chronic inflammation

granted A61KA61K31/12A61K31/137

Quick answer

US patent 10213381 (Solid solution compositions and use in chronic inflammation) held by Infirst Healthcare Limited expires Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Infirst Healthcare Limited
Grant date
Tue Feb 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/12, A61K31/137, A61K31/167, A61K31/19